Synovel Laboratory
Private Company
Funding information not available
Overview
Founded in 2018 and based in Cambridge, USA, Synovel Laboratory is a private, service-oriented CRO specializing in medicinal and process chemistry for small molecule drug discovery and development. The company targets academic labs, startups, and pharmaceutical companies, offering a suite of services including compound design, synthesis, process optimization, and support for advanced modalities like ADCs and PROTACs. It operates as a revenue-generating services business, positioning itself as a high-quality, cost-effective partner to accelerate clients' R&D programs from idea to preclinical candidate.
Technology Platform
Integrated chemistry services with expertise in ADC conjugation chemistry, PROTAC/molecular glue synthesis, and AI-enhanced molecular modeling and virtual screening.
Opportunities
Risk Factors
Competitive Landscape
Synovel competes in the fragmented chemistry CRO market against large players (e.g., Labcorp, Charles River) with full-service scale and numerous small, often offshore, shops competing on cost. Its differentiation is based on high-quality, U.S.-based expertise in complex modern modalities at a competitive price point.